Diamonds and Dogs
5/14/15
Vascular Biogenics Ltd. (VBLT)
Vascular Biogenics has its investors pulse racing today, up 53.90% to $6.28. The clinical stage biopharmaceutical company saw its shares spike after announcing positive results at the ASCO conference. Last night, Vascular Biogenics reported positive, statistically significant data evaluating the efficacy of VB-111 for the treatment of recurrent glioblastoma (rGBM), and expects to initiate a pivotal Phase 3 study in rGBM under a Special Protocol Assessment with the U.S. Food and Drug Administration in mid-2015.Shares of Vascular Biogenics climbed over $2.40 today but never got close to their 52-week high of $17.02.
Health Insurance Innovations Inc. (HIIQ)
Health Insurance Innovations is getting crushed today, down 24.52% to $5.85. The cloud-based health insurance company saw its shares tank after being downgraded by Bank of America Merrill. Early this morning BofA Merrill downgraded the company from "buy" to "neutral", causing investors to head for greener pastures. Shares of Health Insurance Innovations fell nearly $2.00 today and traded within pennies of its 52-week low of $5.30 intradayDiamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.